Page 119 - Read Online
P. 119
Li et al. Cancer Drug Resist. 2025;8:31 Page 25 of 26
24. Zhang Q, Ma Y, Yan Y, Zhang L, Zhang Y. CYB5R1 is a potential biomarker that correlates with stemness and drug resistance in gastric
cancer. Transl Oncol. 2024;39:101766. DOI PubMed PMC
25. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet.
2000;25:25-9. DOI PubMed PMC
26. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27-30. DOI PubMed PMC
27. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS.
2012;16:284-7. DOI PubMed PMC
28. Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. DOI
PubMed PMC
29. Therneau TM, Lumley T. Package ‘survival’. R Top Doc. Available from: https://github.com/therneau/survival. [Last accessed on 23 Jun
2025].
30. Friedman J, Hastie T, Tibshirani R, et al. Lasso and elastic-net regularized generalized linear models. Available from: https://glmnet.stan
ford.edu/. [Last accessed on 23 Jun 2025].
31. Kassambara A, Kosinski M, Biecek P. survminer: Survival analysis and visualization. Available from: https://rpkgs.datanovia.com/surv
miner/index.html. [Last accessed on 23 Jun 2025].
32. Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic
curves for censored event times with competing risks. Stat Med. 2013;32:5381-97. DOI PubMed
33. Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Genome Res. 2018;28:1747-56. DOI PubMed PMC
34. Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-87.e29. DOI PubMed
PMC
35. Abdi H, Williams LJ. Principal component analysis. Wiley Interdiscip Rev Comput Stat. 2010;2:433-59. DOI
36. Mcinnes L, Healy J, Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv 2018;
arXiv:1802.03426. Available from: https://doi.org/10.48550/arXiv.1802.03426. [accessed 23 Jun 2025].
37. van der Maaten L, Hinton G. Visualizing high-dimensional data using t-SNE. J Mach Learn Res 2008;9:2579-605. Available from: https:
//www.jmlr.org/papers/volume9/vandermaaten08a/vandermaaten08a.pdf?fbcl. [Last accessed on 23 Jun 2025].
38. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide
expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-50. DOI PubMed PMC
39. Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers
from cell line screening data. Brief Bioinform. 2021;22:bbab260. DOI PubMed PMC
40. Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery
in cancer cells. Nucleic Acids Res. 2013;41:D955-61. DOI PubMed PMC
41. Zhao R, Wang Y, Zhang M, et al. Screening of potential therapy targets for prostate cancer using integrated analysis of two gene
expression profiles. Oncol Lett. 2017;14:5361-9. DOI PubMed PMC
42. Shalapour S, Font-Burgada J, Di Caro G, et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.
Nature. 2015;521:94-8. DOI PubMed PMC
43. Woo JR, Liss MA, Muldong MT, et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J Transl Med. 2014;12:30. DOI
PubMed PMC
44. Wang B, Zhou Y, Zhang J, Jin X, Wu H, Huang H. Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1
and cancer immunity. Theranostics. 2020;10:1033-45. DOI PubMed PMC
45. Ke ZB, You Q, Chen JY, et al. A radiation resistance related index for biochemical recurrence and tumor immune environment in
prostate cancer patients. Comput Biol Med. 2022;146:105711. DOI PubMed
46. Wang H. MUC5B regulates alterations in the immune microenvironment in nasopharyngeal carcinoma via the Wnt/β-catenin signaling
pathway. Discov Oncol. 2025;16:27. DOI PubMed PMC
47. Juric V, Mayes E, Binnewies M, et al. TREM1 activation of myeloid cells promotes antitumor immunity. Sci Transl Med.
2023;15:eadd9990. DOI PubMed
48. Feng D, Li L, Shi X, et al. Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity
in prostate cancer patients. Aging. 2023;15:9358-76. DOI PubMed PMC
49. Huang X, Shi D, Zou X, et al. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate. Theranostics.
2023;13:339-54. DOI PubMed PMC
50. Tong D. Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype. Crit Rev Oncol Hematol.
2021;163:103370. DOI PubMed
112
